116 related articles for article (PubMed ID: 1701803)
1. Interferon as an agent against herpes simplex virus.
Ho M
J Invest Dermatol; 1990 Dec; 95(6 Suppl):158S-160S. PubMed ID: 1701803
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effects of highly purified bacteria-derived human leukocyte interferons (subtypes A and D) and a human fibroblast interferon against herpes virus infection of the rabbit eye.
Grabner G; Smolin G; Okumoto M; Stebbing N
Curr Eye Res; 1982-1983; 2(11):785-90. PubMed ID: 6313295
[TBL] [Abstract][Full Text] [Related]
3. Effect of a uridine 5'-diphosphate glucose analogue on herpes simplex keratitis in rabbits and vaginal infection in guinea pigs.
Vilas P; Perez C; Perez S; Villalon DG; Gancedo AG; Gil-Fernandez C; Garcia-López MT; de las Heras FG
Chemotherapy; 1989; 35(1):58-63. PubMed ID: 2541977
[TBL] [Abstract][Full Text] [Related]
4. Interferon in the replication of herpes simplex virus in normal and pathological nerve cells.
de De La Peña NC; Bal E; Puricelli L; Diaz A; De Lustig ES
IARC Sci Publ (1971); 1978; (24 Pt 2):1055-66. PubMed ID: 221373
[TBL] [Abstract][Full Text] [Related]
5. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex infections: current concepts and therapy.
Conte ET
J Am Osteopath Assoc; 1983 Jul; 82(11):861-8. PubMed ID: 6885537
[No Abstract] [Full Text] [Related]
7. Herpes simplex virus infection.
Chang TW
Int J Dermatol; 1983; 22(1):1-7. PubMed ID: 6299983
[No Abstract] [Full Text] [Related]
8. The clinical use of human leukocyte interferon in viral infections.
Ikić D; Trajer D; Cupak K; Petricević I; Prazić M; Soldo I; Jusic D; Smerdel S; Soos E
Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):498-505. PubMed ID: 6170597
[TBL] [Abstract][Full Text] [Related]
9. Antiviral drug sensitivity in ocular herpes simplex virus infection.
Menage MJ; de Clercq E; van Lierde A; Easty VS; Darville JM; Cook SD; Easty DL
Br J Ophthalmol; 1990 Sep; 74(9):532-5. PubMed ID: 2168202
[TBL] [Abstract][Full Text] [Related]
10. [Antiviral and non-antiviral general treatments for oro-facial and genital herpes (pregnancy and neonates excluded)].
Guillaume JC
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):625-34. PubMed ID: 12122333
[TBL] [Abstract][Full Text] [Related]
11. [Prevention and therapy of viral diseases with special reference to interferon].
Neumann-Haefelin D
Fortschr Med; 1977 Apr; 95(16):1093-4. PubMed ID: 192653
[TBL] [Abstract][Full Text] [Related]
12. Optimal schedules for use of interferon in the corneas of rabbits with herpes simplex keratitis.
McGill JI; Collins P; Cantell K; Jones BR; Finter NB
J Infect Dis; 1976 Jun; 133 Suppl():A13-7. PubMed ID: 932500
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of herpes keratitis with human leukocyte interferon].
Kaufman HE
Harefuah; 1973 Nov; 85(10):467-8. PubMed ID: 4360802
[No Abstract] [Full Text] [Related]
14. Interferon in treatment of dendritic keratitis in humans: a preliminary report.
Sundmacher R; Neumann-Haefelin D; Manthey KF; Müller O
J Infect Dis; 1976 Jun; 133 Suppl():A160-4. PubMed ID: 180197
[TBL] [Abstract][Full Text] [Related]
15. Primary herpes simplex subepithelial dendritic keratitis.
Stern GA; Zam ZS; Gutgesell VJ
Am J Ophthalmol; 1981 Apr; 91(4):496-9. PubMed ID: 6261583
[TBL] [Abstract][Full Text] [Related]
16. [Herpes simplex virus infections].
Kunkel M; Gärtner L; Oberender H
Z Gesamte Inn Med; 1985 Apr; 40(7):189-93. PubMed ID: 4039869
[TBL] [Abstract][Full Text] [Related]
17. Transfer factor in the treatment of herpes simplex types 1 and 2.
Khan A; Hansen B; Hill NO; Loeb E; Pardue AS; Hill JM
Dermatologica; 1981; 163(2):177-85. PubMed ID: 6974662
[TBL] [Abstract][Full Text] [Related]
18. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.
Richards DM; Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Nov; 26(5):378-438. PubMed ID: 6315332
[TBL] [Abstract][Full Text] [Related]
19. Disease and latency characteristics of clinical herpes virus isolated after acyclovir therapy.
Sibrack CD; McLaren C; Barry DW
Am J Med; 1982 Jul; 73(1A):372-5. PubMed ID: 6285725
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of herpes simplex virus types 1 and 2 to three preparations of human interferon.
Overall JC; Yeh TJ; Kern ER
J Infect Dis; 1980 Dec; 142(6):943. PubMed ID: 6161973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
